title: The tubal hypothesis of ovarian cancer: caution needed.
authors.affiliation: Department of Cancer Medicine, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.
authors.forename: Ian M
authors.initials: IM
authors.lastname: Collins
authors.forename: Susan M
authors.initials: SM
authors.lastname: Domchek
authors.forename: David G
authors.initials: DG
authors.lastname: Huntsman
authors.forename: Gillian
authors.initials: G
authors.lastname: Mitchell
mesh_terms: D019313:BRCA1 Protein / Q000235:genetics; D024682:BRCA2 Protein / Q000235:genetics; D018450:Disease Progression; D019317:Evidence-Based Medicine; D005187:Fallopian Tubes / Q000473:pathology / Q000601:surgery*; D005260:Female; D018095:Germ-Line Mutation; D006801:Humans; D010051:Ovarian Neoplasms / Q000235:genetics / Q000473:pathology / Q000601:surgery*; D010052:Ovariectomy / Q000009:adverse effects; D018579:Patient Selection; D018570:Risk Assessment; D012307:Risk Factors; D058994:Salpingectomy / Q000009:adverse effects; D057170:Translational Research, Biomedical; D016896:Treatment Outcome
chemical_list: D019313:BRCA1 Protein; C492913:BRCA1 protein, human; D024682:BRCA2 Protein; C551750:BRCA2 protein, human